More on GTBP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/17/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GT Biopharma (NQ:GTBP)
Delayed: 6.01 -1.3 (17.78%)
Prev. Close $7.31  
Open$6.81 
52 Wk High$ 
52 Wk Low$ 
Day High$6.90 
Day Low$5.95 
P/E N/A  
EPS$ 
Volume35,229 

Friends, Peers and Foes (?): ONCY, CRBU, FATE, NKTX, LVG (more...)

Oct 21, 2026 06:05 AM Form EFFECT GT Biopharma, Inc.
Oct 20, 2026 05:20 PM Form 424B3 GT Biopharma, Inc.
Oct 13, 2026 05:00 PM Form DEF 14A GT Biopharma, Inc. For: Oct 13
Oct 9, 2026 05:28 PM Form S-1 GT Biopharma, Inc.
Oct 2, 2026 05:27 PM Form PRE 14A GT Biopharma, Inc. For: Oct 02
Sep 29, 2026 01:06 PM Form D GT Biopharma, Inc.
Sep 25, 2026 04:10 PM Form 8-K GT Biopharma, Inc. For: Sep 22
Sep 21, 2026 04:11 PM Form 8-K GT Biopharma, Inc. For: Sep 18
Sep 15, 2026 07:35 PM Form SCHEDULE 13G GT Biopharma, Inc. Filed by: RainForest Partners, LLC
Sep 15, 2026 09:15 AM GT Biopharma receives FDA clearance for GTB-5550 IND in multiple myeloma
View All Articles

Entities mentioned with gtbp

View All Entities